Dr. Gerald Diaz @GeraldMD
23.1M 13.7K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
11 results
management drugs hivaids opportunistic prevention antimicrobials multidrugresistant cdiff dosing medications mycobacterium adjunct antibiotics aviumcomplex candida candidiasis capsulatum cdifficile clostridium clostridiumdifficile
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Drugs Used for the Treatment of COVID-19 Infection LOPINAVIR / RITONAVIR INTERFERON Beta-I REMDESIVIR HYDROXYCHLOROQUINE TOCILIZUMAB Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the Treatment ... of COVID-19 Infection ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with multidrug-resistant tuberculosis,
IDSA Summary of ... multidrug-resistant tuberculosis ... #MDRTB #management ... #pharmacology # ... ebm #idsa
Drugs Used for the Treatment of COVID-19 Infection ** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... of COVID-19 Infection ... HCQ treatment would ... #COVID19 #Pharmacology ... #Table #Management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB) •
IDSA - Clinical ... Individualized Treatment ... are contacts of infectious ... #MDRTB #management ... #regimens #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Clostridium difficile infection ... Episode #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
IDSA Recommendations ... Mycobacterium Tuberculosis ... Please refer to the table ... #TB #IDSA #Prevention ... #HIVAIDS #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode Proven efficacy: • Vancomycin -
Potential Treatment ... Agents for Treatment ... Clostridium difficile infection ... #management #pharmacology ... #idsa #table
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
IDSA Recommendations ... Histoplasma Capsulatum Infections ... with ARV (see Table ... #Prevention #Treatment ... #HIVAIDS #pharmacology
empty